158 related articles for article (PubMed ID: 3860287)
21. Significance of DNA cross-links on 1-(4-amino-2-methylpyrimidin-5-yl)methyl-3-(2-chloroethyl)-3- nitrosourea (ACNU)-induced cytotoxicity against ACNU-sensitive and -resistant lines of 9L rat glioma cells.
Kokunai T; Tamaki N; Matsumoto S
J Natl Cancer Inst; 1987 Jul; 79(1):119-22. PubMed ID: 3474438
[TBL] [Abstract][Full Text] [Related]
22. Neurotoxicity and pharmacokinetics of ventriculolumbar perfusion of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in dogs.
Kochi M; Takaki S; Kuratsu J; Seto H; Kitamura I; Ushio Y
J Neurooncol; 1994; 19(3):239-44. PubMed ID: 7807174
[TBL] [Abstract][Full Text] [Related]
23. Distribution of intrathecally administered ACNU in mongrel dogs: pharmacokinetics and quantitative autoradiographic study.
Hori T; Tanaka S; Nishiyama M; Kamitani H; Watanabe T; Tabuchi F; Tatsuhara T; Nakajima E
Surg Neurol; 1993 Sep; 40(3):183-95. PubMed ID: 8346472
[TBL] [Abstract][Full Text] [Related]
24. Elevated expression of DNA polymerase beta gene in glioma cell lines with acquired resistance to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3- nitrosourea.
Gomi A; Shinoda S; Sakai R; Hirai H; Ozawa K; Masuzawa T
Biochem Biophys Res Commun; 1996 Oct; 227(2):558-63. PubMed ID: 8878552
[TBL] [Abstract][Full Text] [Related]
25. [Therapeutic effects of 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) and radiation on the rat glioma (author's transl)].
Mineura K; Mori T; Katakura R; Sasaki T
No Shinkei Geka; 1981; 9(3):257-65. PubMed ID: 6941099
[No Abstract] [Full Text] [Related]
26. Potentiation by squalene of antitumor effect of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-nitros ourea in a murine tumor system.
Yamaguchi T; Nakagawa M; Hidaka K; Yoshida T; Sasaki T; Akiyama S; Kuwano M
Jpn J Cancer Res; 1985 Oct; 76(10):1021-6. PubMed ID: 3935620
[TBL] [Abstract][Full Text] [Related]
27. In vitro cytotoxicity and differential cellular sensitivity of derivatives of diamino acids. II. N1-methyl, N1-allyl, N1-(2-chloroethyl) and N1-propargyl nitrosoureas.
Dulude H; Salvador R; Gallant G
Anticancer Res; 1995; 15(3):853-8. PubMed ID: 7645970
[TBL] [Abstract][Full Text] [Related]
28. Mutagenic activity of nitrosourea antitumor agents.
Franza BR; Oeschger NS; Oeschger MP; Schein PS
J Natl Cancer Inst; 1980 Jul; 65(1):149-54. PubMed ID: 6446611
[TBL] [Abstract][Full Text] [Related]
29. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
Fujimoto S; Tashiro T; Ogawa M
Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
[TBL] [Abstract][Full Text] [Related]
30. Transient induction of the MRP/GS-X pump and gamma-glutamylcysteine synthetase by 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3- nitrosourea in human glioma cells.
Gomi A; Shinoda S; Masuzawa T; Ishikawa T; Kuo MT
Cancer Res; 1997 Dec; 57(23):5292-9. PubMed ID: 9393752
[TBL] [Abstract][Full Text] [Related]
31. Lethal toxicity and myelotoxicity to mice of the combination of 6-thioguanine and 3-[(4-amine-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride.
Fujimoto S; Ogawa M
Gan; 1980 Oct; 71(5):667-73. PubMed ID: 6939646
[TBL] [Abstract][Full Text] [Related]
32. Neurotoxicity of local administration of two nitrosoureas in malignant gliomas.
Yamashima T; Yamashita J; Shoin K
Neurosurgery; 1990 May; 26(5):794-9. PubMed ID: 2352597
[TBL] [Abstract][Full Text] [Related]
33. [Topical application of ACNU for the treatment of mycosis fungoides].
Jimbow K; Horikoshi T; Kamimura M
Gan To Kagaku Ryoho; 1982 Jul; 9(7):1231-6. PubMed ID: 6964047
[TBL] [Abstract][Full Text] [Related]
34. Cisplatin represses transcriptional activity from the minimal promoter of the O6-methylguanine methyltransferase gene and increases sensitivity of human gallbladder cancer cells to 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-2-chloroethyl)-3-nitrosourea.
Sato K; Kitajima Y; Nakagawachi T; Soejima H; Miyoshi A; Koga Y; Miyazaki K
Oncol Rep; 2005 May; 13(5):899-906. PubMed ID: 15809756
[TBL] [Abstract][Full Text] [Related]
35. Alteration of blood-CSF barrier by tumor invasion into the meninges.
Ushio Y; Shimizu K; Aragaki Y; Arita N; Hayakawa T; Mogami H
J Neurosurg; 1981 Sep; 55(3):445-9. PubMed ID: 6943305
[TBL] [Abstract][Full Text] [Related]
36. [Anti-tumor activity of ACNU against malignant glioma--a clinical application of in vitro sensitivity test of chemotherapeutic agent].
Shibuya N; Yoshida J; Kobayashi T; Kageyama N
No Shinkei Geka; 1983 Apr; 11(4):361-7. PubMed ID: 6306497
[TBL] [Abstract][Full Text] [Related]
37. [Intrathecal ACNU against malignant leptomeningeal tumors--toxicity and therapeutic effect in experimental animals].
Nagatani M; Arita N; Ushio Y; Hayakawa T; Tzuu-Yuan H; Yoshimine T; Mori S; Mogami H
No To Shinkei; 1986 Nov; 38(11):1071-5. PubMed ID: 3468960
[TBL] [Abstract][Full Text] [Related]
38. Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
Fujimoto S; Ogawa M; Hoshino A
Gan; 1980 Feb; 71(1):60-72. PubMed ID: 6929770
[TBL] [Abstract][Full Text] [Related]
39. Specific induction of ACNU-resistance in V79 Chinese hamster cells and C6 rat glioma cells.
Horie Y; Arai K; Endoh S; Kuroki T; Takaku A
J Neurosurg; 1987 Oct; 67(4):553-7. PubMed ID: 3477613
[TBL] [Abstract][Full Text] [Related]
40. Isolation and preliminary characterization of ACNU-resistant sublines of rat brain tumors in vivo.
Yoshida TK; Shimizu K; Koulousakis A; Sturm V; Beuls E
J Neurosurg; 1992 Sep; 77(3):451-6. PubMed ID: 1506893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
